CWP
Concord Wealth Partners’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535 | Buy |
+11
| New | +$535 | ﹤0.01% | 785 |
|
|
2024
Q4 | – | Sell |
-11
| Closed | -$517 | – | 936 |
|
|
2024
Q3 | $517 | Sell |
11
-9
| -45% | -$423 | ﹤0.01% | 894 |
|
|
2024
Q2 | $1.08K | Sell |
20
-11
| -35% | -$594 | ﹤0.01% | 722 |
|
|
2024
Q1 | $2.11K | Buy |
31
+11
| +55% | +$750 | ﹤0.01% | 750 |
|
|
2023
Q4 | $1.25K | Sell |
20
-139
| -87% | -$8.7K | ﹤0.01% | 748 |
|
|
2023
Q3 | $7.22K | Sell |
159
-126
| -44% | -$5.72K | ﹤0.01% | 668 |
|
|
2023
Q2 | $16K | Buy |
285
+66
| +30% | +$3.71K | ﹤0.01% | 538 |
|
|
2023
Q1 | $9.91K | Sell |
219
-1,096
| -83% | -$49.6K | ﹤0.01% | 596 |
|
|
2022
Q4 | $53.5K | Buy |
+1,315
| New | +$53.5K | 0.02% | 366 |
|
|
2022
Q3 | – | Sell |
-2,873
| Closed | -$175K | – | 350 |
|
|
2022
Q2 | $175K | Buy |
2,873
+1,685
| +142% | +$103K | 0.05% | 173 |
|
|
2022
Q1 | $75K | Buy |
1,188
+392
| +49% | +$24.7K | 0.02% | 350 |
|
|
2021
Q4 | $60K | Buy |
796
+585
| +277% | +$44.1K | 0.01% | 423 |
|
|
2021
Q3 | $24K | Sell |
211
-339
| -62% | -$38.6K | 0.01% | 346 |
|
|
2021
Q2 | $89K | Sell |
550
-25
| -4% | -$4.05K | 0.03% | 253 |
|
|
2021
Q1 | $70K | Buy |
+575
| New | +$70K | 0.02% | 276 |
|